Connect with us

PR Newswire

HTC VIVE Takes Business and Consumer VR to the Next Level with Two New VR Headsets and a Dedicated Suite of Professional Tools

Published

on

BEIJING, May 11, 2021 /PRNewswire/ — HTC VIVE, the global leader in premium virtual reality (VR), sets a new benchmark for business and consumer VR, bringing 5K resolution and a 120-degree field of view as standard to the two new VR headsets announced today at the 2021 VIVE Virtual Ecosystem Conference (V2EC 2021).

VIVE FOCUS 3 redefines All-in-One VR with no compromises while VIVE PRO 2 pushes the boundaries of PC VR for incredible gaming, designing, and experiences. HTC also announced VIVE BUSINESS, its comprehensive range of tools designed to support businesses of any size to get the most out of VR.

“In line with our mission, we’ve combined the very latest technology with the needs and aspirations of our customers, enabling them to unleash their imagination to improve people’s lives and solve problems for business and society,” said Cher Wang, HTC Chairwoman and CEO, in the welcome speech for the conference. “Today’s launch marks a major milestone in our strategy to create the very best immersive experiences. We have listened to our customers, from well-known global companies to smaller firms and professional users, and have designed these premium headsets from the ground up to meet the challenges they face, adding a professional range of software, platform and services to make implementation as smooth and effective as possible。”

HTC China President Alvin Graylin Wang stated that, “VR is a technology that has the potential to fundamentally transform our lives, and 2021 will be the year people look back on as the year it really started to take off. The products and services we announced today are the key catalyst that will ignite the VR revolution by setting a new standard for what quality VR should be. Having a single device that can be used standalone, connect with a PC or 5G Cloud VR network, can be comfortably worn for many hours, while delivering a new level of clarity that not only can take you to another world but can also replace your daily monitor, will lead to accelerated adoption of VR in the near future.”

This HTC Vive Virtual Ecosystem Conference was held in VIVE SESSIONS, a virtual meeting platform provided in HTC’s VIVE XR SUITE. Together with HTC’s global virtual conference VIVECON, they have attracted more than 50,000 users registered for live interactive participation. The first V2EC last March was one of the world’s first large-scale industrial virtual conferences and this year have elevated all aspects of the event to a new level with over 10x attendance and 3x the content. 

At this year’s event, HTC China also unveiled its new virtual human character, VEE, to demonstrate the application of cutting-edge avatar and tracking technology in a Metaverse use case.

Continuous product innovation to enhance productivity

Since the launch of its first VR product in 2016, HTC Vive has provided a strong hardware lineup for enterprise users and consumers to truly feel the potential of XR as the next-generation computing platform. At V²EC 2021, HTC Vive didn’t disappoint with a range of newly launched hardware products.

VIVE Focus 3 – A New Era for VR

The new VIVE Focus 3 is the ultimate solution for standalone VR, combining outstanding visuals with a smarter ergonomic design, superior audio and next level inside-out tracking and controllers. VIVE Focus 3 will be on-the-shelf in China in late June, for RMB¥9888 (includes 24 month VIVE Business Warranty and Services).

VIVE Focus 3 is powered by the premium-quality Qualcomm® Snapdragon™ XR2 Platform which unlocks staggering performance improvements including twice the CPU and GPU performance and 11x the AI processing compared to its predecessor[1] which powers the original VIVE Focus.

The VIVE Focus 3 has delivered class-leading specs in a standalone device, with a combined 5K resolution, a smooth 90Hz refresh rate and an ultra-wide 120-degree field of view, for exceptional immersion. The new visuals mean fine details like text and overall fidelity are dramatically clearer, allowing for the potential to work, learn and browse comfortably in VR and replace existing monitors. At the conference, the VIVE Focus 3 was shown to deliver a high-definition personal virtual workspace supporting a physical keyboard and mouse via a custom version of vSpatial.

VIVE Focus 3 delivers industry-leading comfort, with a new strap design, balanced front-back weight distribution, and an intelligently designed curved swappable battery pack. VIVE Focus 3’s battery pack can be changed in seconds, allowing you to keep going for a non-stop day. Its quick-charge feature can give users 50% battery from just 30 minutes of charging, and an external L.E.D indicator lets you know how much power you have left.

Durable and lightweight, the magnesium alloy frame of VIVE Focus 3 is 20% lighter and 500% stronger than traditional plastics. VIVE Focus 3 has a wide range and fine-adjustable Inter-Pupillary Distance (IPD) range, as well as a quick-release head-strap button and magnetic front and rear face gaskets – so it’s quick and effortless to swap in replacements or clean them – which is especially important for multi-user scenarios.

When additional processing power is needed, the newly announced VIVE Business Streaming function will support connecting the VIVE Focus 3 to a VR-Ready PC to access all existing PC-VR content. The certified Vive Streaming Cable will be available for RMB¥699 when the VIVE Focus 3 ships and the wireless streaming function is expected to arrive soon.

VIVE Focus 3 has new open-back speakers featuring a pair of dual drivers, delivering immersive and true-to-life audio. For peace of mind in VR meetings, a special audio privacy setting dramatically reduces the risk of being overheard by people nearby.

VIVE Focus 3 uses a proprietary AI-powered inside-out tracking algorithm for precise tracking, with privacy at the forefront as all tracking data is stored in an encrypted format on the headset. The redesigned controllers are easy and intuitive to use – one of the lightest 6dof controllers on the market and it still lasts for 15 hours on a single charge. Hand tracking support will be released in the near future.

To reward customers that purchase the VIVE Focus 3 in Q2, HTC will plan to bundle a three-month free license of the entire VIVE XR Suite (RMB¥400 value) and a six-month free license of VIVE Sync (RMB¥1500 value).

VIVE Pro 2 – Sharp, Precise, Immersive

The VIVE Pro 2 takes PC VR to the next level, when every pixel and polygon counts, for high-end gaming or creating the impossible. VIVE Pro 2 in the headset-only version will be on-the-shelf in China for RMB¥6888.

A stunning 5K resolution display delivers 2.5K to each eye, coupled with a beautifully fluid 120 Hz refresh rate, and a fast-switching panel with real RGB sub-pixels, for crystal clear and super smooth animations. The field of view increases to 120 degrees thanks to VIVE Pro 2’s new bespoke dual stacked-lens design. These advances mean minimal motion blur and the screen-door effect often seen in other devices is virtually eliminated, giving people a more natural and immersive experience.

HTC VIVE also worked closely with NVIDIA and AMD to utilize Display Stream Compression for the first time in a VR headset. Display Stream Compression ensures maximum visual quality and is also backwards compatible with DisplayPort 1.2, so even graphics cards that supported VIVE Pro will see a benefit with VIVE Pro 2.

VIVE Pro 2 has fine-adjustable inter-pupillary distance (IPD), evenly distributed weight balance, adjustable head strap, and a quick-adjustable sizing dial. Perfect for finding your personal preferences, and also sharing the experience with others. VIVE Pro 2 has 3D spatial sound with Hi-Res Audio Certified headphones and supports third-party headphones.

All VIVE SteamVR ecosystem accessories will work with VIVE Pro 2 – VIVE Trackers of any generation, the new VIVE Facial Tracker, and more. VIVE Pro 2 will slot into an existing SteamVR setup – whether it’s Base Station 1.0 or Base Station 2.0, VIVE Wireless Adapter, VIVE controllers, or even controllers and gloves like Valve’s Index ‘knuckles’ controllers.

For customers that need eye-tracking capabilities in their VR devices, VIVE X portfolio company, 7Invensun will be shipping its Droolon F2 eye-tracking accessory for both the Vive Pro 2 and Vive Focus 3 in Q3.

All VIVE Pro 2 customers will have the chance to receive the VIVE XR Suite 3-month free license (RMB¥400 value).

VIVE BUSINESS – Bring everything to VR work

VIVE Business is a complete suite of software and services, supporting the needs of businesses looking to get the best out of XR. No matter your organization’s size, VIVE Business is scalable and secure, making life easier for deployment, maintenance, remote support, training needs, and much more.

Building on the success of the consumer VIVEPORT store, the VIVE Business App Store is a curated collection of apps and tools, covering six areas include remote collaboration, therapy & rehabilitation, training, design & marketing visualization, learning & education, location-based experiences. It’s simple to pick an app off-the-shelf, or even get in touch with the creator to tailor it for specific needs.

To further enrich the content and attract more developers to join the ecosystem, HTC VIVE has launched a new developer partnership program, Vive Independent Software Vendor (ISV) program beta version. Developers who join the ISV program can get additional support from HTC Vive to help develop better solutions. By doing so, HTC can provide enterprises with reliable developer partners and tailor-made VR solutions. At present, more than 50 partners worldwide have signed the plan. Developers can visit https://business.vive.com/isv for more details.

The VIVE Business Device Management System is a simple and intuitive MDM and is ISO certified, allowing IT to quickly and easily see the status of each VIVE Focus 3 on the network, remotely install new business apps, update software, and more. VIVE Focus 3 is designed to work with Android Enterprise MDM, so it can also slot into pre-existing MDM solutions already active in your environment.

VIVE Business Training is perfect to support training sessions of any size. The training leader can observe the progress of each trainee, via an Android device, highlighting the next steps needed and talking the trainee through it, even in a class size of hundreds.

Vive gives control back to businesses. Organizations can choose to take up VIVE Business services, or they can simply pay a one-off cost for VIVE Focus 3 and integrate it into their existing setup, with no recurring fees and the ability to use their hardware as they choose to.

Deepening the layout of XR with partnerships in multiple fields

The HTC Vive Virtual Ecosystem Conference not only released the top-level hardware in the VR industry, but also showed the entire industry its all-around development in multiple fields. Close cooperation with partners such as Qualcomm, AMD, Nvidia, etc., has maximized the release of the possibility of VR products at the hardware level. HTC Vive’s in-depth partnership with leading companies such as CMCC, HP and V&A museum also demonstrates the remarkable result of HTC VIVE’s strategy of taking both software and hardware into consideration.

“Since we launched VIVE in 2016, we’ve continuously worked to create a healthy VR ecosystem. We are so glad to see so many strong companies join us to announce partnerships and offerings to strengthen the industry,” said Alvin Wang Graylin, HTC China President. “Our expanding coop with HP will help make XR Suite more accessible to companies of all sizes, Qualcomm continues to be a strong partner as we grow the XR industry together, CMCC’s work will help make mobile VR more standardized, and the many ISV partners in the Vive Business App Store will all help solve our customers business problems more efficiently than ever before.”

In order to attract more entrepreneurs, investors and partners to build the XR ecosystem together, VIVE X Accelerator will join the Virtual Reality Venture Capital Alliance (VRVCA) to host a Virtual Roadshow. In this roadshow, participants will have the opportunity to connect with the best XR startups around the world and key leads & partners from top VSs and funds. Qualified startups can apply for a spot to pitch at: http://vivexshenzhen.mikecrm.com/lxUCvwo

Virtual idol debut, to endorse the XR world

“XR has redefined many scenarios in the post-digital era, and the rich media experience brought to users by XR technology is particularly interesting,” mentioned Chen Wu, managing director of “The Economist Business Review”, in the dialogue session of the conference. In recent years, new content formats such as XR production and XR live entertainment have enabled more users to intuitively feel the charm of the XR world. The virtual idol that combines XR’s cutting-edge technology and the interactive form of social media has also become a shining star in the XR ecosystem.

At this conference, HTC Vive also unveiled its virtual human character, Vee, who was animated using VIVE Tracker motion capture, face tracking and other XR technologies. According to her backstory, Vee is a virtual space traveler who comes from the future VIVE Reality. In an accident, she teleported back into the current day virtual world. Vee, who has witnessed the future “metaverse”, is determined to stay in the present and help us build a more complete virtual world to improve all people’s lives.

“I’m quite excited about today’s unveiling of Vive’s own virtual character, Vee.  She was fully developed by the Vive China team and her character is intended to represent the raw energy of a new generation of users whose lives will become as intertwined with XR devices in the near future, as we are with mobile devices today,” said Alvin Wang Graylin, “We look forward to sharing more about her with everyone in future virtual activities”

As Ms. Xiaoya Chen, Executive Vice President of CIUR and Former Vice Minister of the Ministry of Education and Ministry of Science and Technology, said at the conference, “In the era of the smart economy, all the industries are striving to achieve intelligence.” At V2EC 2021, a seamless commercial solution integrating software and hardware products and services has been newly implemented. It will extend the XR technology to more application fields and bring changes to more industries.

[1] Compared to Qualcomm® Snapdragon™ 835 Mobile XR Platform

About HTC

HTC VIVE is the premier virtual reality (VR) platform and ecosystem that creates true-to-life VR experiences for businesses and consumers. The VIVE ecosystem is built around premium VR hardware, software, and content. The VIVE business encompasses best-in-class XR hardware; VIVEPORT platform and app store; VIVE Enterprise Solutions for business customers; VIVE X, a US$100M VR business accelerator; and VIVE ARTS for cultural initiatives. For more information, please visit www.vive.com.

SOURCE HTC VIVE

Related Links

http://www.vive.com

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://www.prnewswire.com:443/news-releases/htc-vive-takes-business-and-consumer-vr-to-the-next-level-with-two-new-vr-headsets-and-a-dedicated-suite-of-professional-tools-301289328.html

PR Newswire

Perfect World to pioneer digital culture and creative sector in joint hands with partners

Published

on

As a world’s leading entertainment group, Perfect World proposed “Creative Thinking” strategy, aiming at breaking the barrier of the real world and virtual world, and combining new types of games with traditional industries so as to empower the development of traditional industries and promote digital upgrade of traditional industries as well.

Under the “Creative Thinking” strategy, Perfect World has made significant achievements in its cooperation with enterprises and institutions, such as implanting scenes of the Qinhuai Lantern Fair of Nanjing Confucius Temple into its famous game “Zhuxian,” and the collaboration between its mobile game Chronicle of Infinity and the famous sports brand Peak.

Perfect World CEO Dr. Robert H. Xiao said at the conference that after all the successful cases, Perfect World has been more confident about cross-over cooperation between digital culture industry and traditional industries. He promised that Perfect World will keep exploring to establish a value chain that empowers traditional industries, and incubate more new types of culture content, products, and business models.

In its collaboration with Nianhuawan scenic spot in Wuxi, Perfect World gamified the scenic spots, and brought tourists an immersive experience by combing the scenic spot and the digital world. The move helps the scenic spot to upgrade from service-based economic to experience economy.

“Not only will we explore subdivided fields with partners, but also work as a bridge to promote cross-over cooperation among companies in various fields, so as to achieve common development,” said Dr. Xiao. “And we hope to joint hands with our partners to unlock a new track in this ‘experimental production’ of the culture industry that faces the future,” he added.

Perfect World will tailor a whole set of solutions and plans on digital upgrading partners’ products based on their requirements. For example, in its cooperation with Shanghai Science and Technology Museum, Perfect World will develop a game to turn the complicated scientific knowledge into visions to help readers understand the scientific knowledge. The Group will also have an in-depth cooperation with China Audio-video and Digital Publishing Association in the field of education and vocational training such as e-sports talent cultivation.

The culture department of Beijing’s Dongcheng district, People’s Cultural Tourism of People’s Daily, a cultural & creative institute affiliated to Tsinghua University, Beijing Dongsheng Bozhan Cloud Computing Technology Co., Ltd., and Nianhuawan scenic spot, also signed strategic cooperation agreements with Perfect World in the brand cooperation conference.

SOURCE Perfect World

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://www.prnewswire.com:443/news-releases/perfect-world-to-pioneer-digital-culture-and-creative-sector-in-joint-hands-with-partners-301311222.html

Continue Reading

PR Newswire

European Hematology Association : la réponse humorale au vaccin Pfizer/BioNTech BNT162b2 est altérée chez les patients recevant un CAR-T ou un traitement immunosuppresseur de haute intensité

Published

on

LA HAYE, Pays-Bas, 12 juin 2021 /PRNewswire/ — Le vaccin Pfizer/BioNTech BNT162b2 a été approuvé pour la prévention de l’infection par le coronavirus 2 du syndrome respiratoire aigu sévère (SRAS-CoV-2) et est recommandé pour les patients immunodéprimés. Cependant, son efficacité et son innocuité chez les patients suivant une thérapie cellulaire immunologique n’ont pas été bien documentées. Dans le cadre de cette étude, nous avons évalué l’efficacité et l’innocuité du vaccin BNT162b2 chez les patients ayant subi une greffe de cellules hématopoïétiques (HCT) et un traitement au récepteur d’antigène chimérique (CAR)-T. Nous avons suivi prospectivement 79 patients vaccinés ayant été activement traités au Centre médical Sourasky de Tel Aviv et surveillé le profil d’innocuité et la réponse immunitaire humorale au vaccin.

Dans l’ensemble, le vaccin a été bien toléré et tous les effets indésirables se sont résorbés en quelques jours, à l’exception d’un rejet de greffe secondaire, qui fait toujours l’objet d’une enquête. Nous avons observé que seulement 36 % des patients ayant reçu un traitement CAR-T ont développé une réponse aux anticorps humoraux comparativement à 81 % des patients ayant subi une TSS allogénique. De plus, les patients atteints d’aplasie des cellules B et ceux ayant reçu le vaccin peu après la perfusion de cellules étaient moins susceptibles de développer des anticorps. Prises ensemble, ces données démontrent que la réponse humorale au vaccin BNT162b2 est significativement altérée chez les patients recevant le CAR-T, par opposition à ceux ayant reçu une TSS allogénique ayant une bonne réponse.

Présentateur : Professeur Ron Ram

Affiliation : Unité BMT, Tel Aviv Sourasky Medical Center, Tel Aviv, Israël

Résumé : #S285 INNOCUITÉ ET EFFICACITÉ DU VACCIN BNT162B2 MRNA COVID-19 CHEZ LES PATIENTS APRÈS UNE THÉRAPIE ALLOGÉNIQUE À BASE DE HCT ET DE CD19 – ÉTUDE DE COHORTE PROSPECTIVE À UN SEUL CENTRE

À propos du congrès annuel de l’AEH : Chaque année, en juin, l’AEH organise son congrès annuel dans une grande ville européenne. Cette année, en raison de la persistance de la pandémie de COVID-19, l’AEH organise pour la deuxième fois un Congrès virtuel. Le Congrès s’adresse aux professionnels de santé travaillant dans le domaine de l’hématologie ou s’y intéressant. Les sujets du programme scientifique vont de la physiologie et du développement des cellules souches à la leucémie, le lymphome, le diagnostic et le traitement, les globules rouges, les globules blancs et les troubles plaquettaires, l’hémophilie et le myélome, la thrombose et les troubles de la coagulation ainsi que la transfusion et la transplantation de cellules souches.

Site web :www.ehaweb.org

Logo – https://mma.prnewswire.com/media/622259/EHA_Logo.jpg

SOURCE European Hematology Association (EHA)

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://www.prnewswire.com:443/news-releases/european-hematology-association-la-reponse-humorale-au-vaccin-pfizer-biontech-bnt162b2-est-alteree-chez-les-patients-recevant-un-car-t-ou-un-traitement-immunosuppresseur-de-haute-intensite-862309567.html

Continue Reading

PR Newswire

EHA:Eficacia de la vacuna Pfizer/BioNTech BNT162b2 en pacientes que reciben CAR-T

Published

on

– European Hematology Association:La respuesta humoral a la vacuna Pfizer/BioNTech BNT162b2 se ve afectada en pacientes que reciben CAR-T o terapia inmunosupresora de alta intensidad

LA HAYA, Países Bajos, 12 de junio de 2021 /PRNewswire/ — La vacuna Pfizer/BioNTech BNT162b2 ha sido aprobada para la prevención del síndrome respiratorio agudo severo por coronavirus 2 (SARS-CoV-2) y se recomienda para pacientes inmunosuprimidos. Sin embargo, su eficacia y seguridad en pacientes sometidos a terapia celular inmunológica no han sido bien documentadas. En este estudio, evaluamos la eficacia y seguridad de la vacuna BNT162b2 en pacientes que se sometieron a trasplante de células hematopoyéticas (HCT) y terapia con receptor de antígeno quimérico (CAR) -T. Seguimos prospectivamente a 79 pacientes vacunados que fueron tratados activamente en el Centro Médico Sourasky de Tel Aviv y monitoreamos el perfil de seguridad y la respuesta inmune humoral a la vacuna.

En general, la vacuna fue bien tolerada y todos los efectos secundarios se resolvieron en unos pocos días, excepto un rechazo secundario del injerto, que aún está bajo investigación. Observamos que solo el 36% de los pacientes que recibieron terapia CAR-T desarrollaron una respuesta humoral de anticuerpos en comparación con el 81% de los pacientes que se sometieron a un HCT alogénico. Además, los pacientes con aplasia de células B y los que recibieron la vacuna poco después de la infusión de células tenían menos probabilidades de desarrollar anticuerpos. Tomados en conjunto, estos datos demuestran que la respuesta humoral a la vacuna BNT162b2 está significativamente alterada en los pacientes que reciben CAR-T, a diferencia de aquellos después de un HCT alogénico que tuvieron una buena respuesta.

Presentador:  Profesor Ron Ram

Afiliación:  BMT Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Abstract: #S285  SAFETY AND EFFICACY OF THE BNT162B2 MRNA COVID-19 VACCINE IN PATIENTS AFTER ALLOGENEIC HCT AND CD19-BASED CAR-T THERAPY – A SINGLE CENTER PROSPECTIVE COHORT STUDY

Acerca del Congreso anual de EHA: Cada junio, la EHA organiza su Congreso Anual en una de las principales ciudades europeas. Este año, debido a la persistente pandemia de COVID19, EHA organiza un Congreso virtual por segunda vez. El Congreso está dirigido a profesionales de la salud que trabajen o estén interesados en el campo de la hematología. Los temas del programa científico van desde la fisiología y el desarrollo de las células madre hasta la leucemia; linfoma diagnostico y tratamiento; las células rojas de la sangre; trastornos de los glóbulos blancos y las plaquetas; hemofilia y mieloma; trombosis y trastornos hemorrágicos; así como transfusión y trasplante de células madre.

Sitio web: www.ehaweb.org

Logo – https://mma.prnewswire.com/media/622259/EHA_Logo.jpg

SOURCE European Hematology Association (EHA)

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://www.prnewswire.com:443/news-releases/eha-eficacia-de-la-vacuna-pfizer-biontech-bnt162b2-en-pacientes-que-reciben-car-t-868759422.html

Continue Reading

PR Newswire

European Hematology Association: Overall Survival Benefit Established With Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) in Elderly Patients with Transplant-ineligible Newly Diagnosed Multiple Myeloma (NDMM): Long-Term Interim Analysis of the MAIA Study

Published

on

THE HAGUE, Netherlands, June 12, 2021 /PRNewswire/ — The phase 3 MAIA study evaluated D-Rd versus Rd in 737 patients who were ineligible for high-dose chemotherapy and autologous stem cell transplantation. The primary analysis of MAIA demonstrated a 44% reduction in the risk of disease progression or death after treatment with D-Rd compared with Rd alone. At a median follow-up of almost 5 years (56.2 months), we now report the pre-specified interim overall survival analysis of MAIA.

The addition of daratumumab to Rd treatment significantly reduced the risk of death by 32% (hazard ratio, 0.68; 95% confidence interval [CI], 0.53-0.86; P=0.0013) with an estimated 5-year overall survival rate of 66.3% in the D-Rd group compared with 53.1% in the Rd alone group. These results are despite 46% of patients who received subsequent therapy in the Rd arm receiving daratumumab. Similarly, the significant progression-free survival benefit of D-Rd versus Rd that was identified in the primary analysis was maintained, with a 47% reduction in the risk of disease progression or death (HR, 0.53; 95% CI, 0.43-0.66; P<0.0001) and an estimated 60-month progression-free survival rate of 52.5% versus 28.7%, respectively; these data provide a new PFS benchmark for patients with NDMM who are transplant ineligible. The high overall response rate (93% vs 82%) further demonstrated the added clinical benefit of D-Rd versus Rd alone. No new safety concerns were identified for D-Rd and the most common (>15%) grade 3/4 treatment-emergent adverse events for D-Rd and Rd were neutropenia (54% vs 37%), pneumonia (19% vs 11%), anemia (17% vs 22%), and lymphopenia (16% and 11%). In conclusion, the clinical benefit from the primary analysis of the MAIA study was maintained through 5 years of follow-up and the benefit of upfront D-Rd given to progression was confirmed with a significant OS improvement, further supporting the use of frontline daratumumab as a new standard of care for patients with transplant-ineligible NDMM.

The results of this study will be presented by Prof. Thierry Facon on Saturday, June 12.

Presenter: Professor Thierry Facon

Affiliation: University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France

Abstract: #LB1901 OVERALL SURVIVAL RESULTS WITH DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE VERSUS LENALIDOMIDE AND DEXAMETHASONE IN TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: PHASE 3 MAIA STUDY

About the EHA Annual Congress: Every year in June, EHA organizes its Annual Congress in a major European city. This year due to the persisting COVID19 pandemic, EHA organized a Virtual Congress for the second time. The Congress is aimed at health professionals working in or interested in the field of hematology.

Website: www.ehaweb.org

Logo – http://mma.prnewswire.com/media/622259/EHA_Logo.jpg

SOURCE European Hematology Association (EHA)

Related Links

https://ehaweb.org/

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://www.prnewswire.com:443/news-releases/european-hematology-association-overall-survival-benefit-established-with-daratumumab-plus-lenalidomide-and-dexamethasone-d-rd-in-elderly-patients-with-transplant-ineligible-newly-diagnosed-multiple-myeloma-ndmm-long-term-in-301310175.html

Continue Reading
Esports3 days ago

Genshin Impact Echoing Conch Locations Guide

Esports5 days ago

All 17 character locations in Collections in Fortnite Chapter 2, season 7

Esports4 days ago

Here are all the milestones in Fortnite Chapter 2, season 7

AI5 days ago

How to Become a 21st Century Engineer?

Blockchain5 days ago

BPI No Longer Allows Crypto Transactions

AR/VR5 days ago

‘Warhammer Age of Sigmar: Tempestfall’ Gets First Look at Gameplay, Invite-only Beta

Blockchain4 days ago

Doge meme Shiba Inu dog to be auctioned off as NFT

Esports4 days ago

What Time Does Minecraft 1.17 Release?

Esports4 days ago

How to Fly UFOs in Fortnite

Esports3 days ago

MLB The Show 21 Kitchen Sink 2 Pack: Base Round Revealed

Blockchain4 days ago

World Economic Forum Releases a DeFi Policy Toolkit for Fair and Executable Regulations

Esports5 days ago

How to unlock the Superman Skin in Fortnite Chapter 2, season 7

Blockchain5 days ago

Donald Trump on Bitcoin: “Essentially It’s a Currency Competing Against the Dollar”

zephyrnet3 days ago

7th Global Blockchain Congress by Agora Group & TDeFi on June 21st and 22nd, 2021, Dubai.

Esports5 days ago

How to get Rick from Rick and Morty in Fortnite Chapter 2, season 7

Aviation2 days ago

The Story Of The Boeing 777 Family

Blockchain3 days ago

Woonkly will be the official Title Sponsor of the 7th edition Global Blockchain Congress organized by Agora Group in Dubai

Gaming4 days ago

MUCK: How To Get The Best Weapon | Wyvern Dagger Guide

Cyber Security5 days ago

GRC and Cyber Security Must Unite

Fintech5 days ago

NANOBIOTIX to Host Virtual KOL Event Discussing Potential First-in-Class Radioenhancer NBTXR3 In Immunotherapy on June 11, 2021

Trending